CompletedPhase 4

Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.

NCT01649466

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Investigative Site

Anderbeck, Germany

+52 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-08
Enrollment: 162 participants
Sponsor: Novartis Pharmaceuticals
Purpose: treatment

Locations (53)

Novartis Investigative SiteAnderbeck, Germany
Novartis Investigative SiteAugsburg, Germany
Novartis Investigative SiteBad Kreuznach, Germany
Novartis Investigative SiteBad Oeynhausen, Germany
Novartis Investigative SiteBalingen, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteCologne, Germany
Novartis Investigative SiteDortmund, Germany
Novartis Investigative SiteDresden, Germany
Novartis Investigative SiteDresden, Germany
Novartis Investigative SiteEinbeck, Germany
Novartis Investigative SiteEisleben Lutherstadt, Germany
Novartis Investigative SiteElsterwerda, Germany
Novartis Investigative SiteEssen, Germany
Novartis Investigative SiteEssen, Germany
Novartis Investigative SiteFulda, Germany
Novartis Investigative SiteGelnhausen, Germany
Novartis Investigative SiteGraben-Neudorf, Germany
Novartis Investigative SiteGrossheirath-Rossach, Germany
Novartis Investigative SiteHerne, Germany
Novartis Investigative SiteHildesheim, Germany
Novartis Investigative SiteKassel, Germany
Novartis Investigative SiteKassel, Germany
Novartis Investigative SiteKleve, Germany
Novartis Investigative SiteLienen, Germany
Novartis Investigative SiteLöhne, Germany
Novartis Investigative SiteMagdeburg, Germany
Novartis Investigative SiteMainz, Germany
Novartis Investigative SiteMayen, Germany
Novartis Investigative SiteMülheim, Germany
Novartis Investigative SiteMünchen, Germany
Novartis Investigative SiteMünchen, Germany
Novartis Investigative SiteOschatz, Germany
Novartis Investigative SitePotsdam, Germany
Novartis Investigative SiteReinfeld, Germany
Novartis Investigative SiteSaarlouis, Germany
Novartis Investigative SiteSaint Ingbert - Oberwuerzbach, Germany
Novartis Investigative SiteSchliemannstadt Neubukow, Germany
Novartis Investigative SiteStraubing, Germany
Novartis Investigative SiteStuttgart, Germany
Novartis Investigative SiteVillingen-Schwenningen, Germany
Novartis Investigative SiteWallerfing, Germany
Novartis Investigative SiteWangen, Germany
Novartis Investigative SiteWedemark, Germany
Novartis Investigative SiteWeiskirchen, Germany
Novartis Investigative SiteWetzlar-Naunheim, Germany
Novartis Investigative SiteWurzen, Germany
Novartis Investigative SiteWürzburg, Germany